Effects of nasal strips on sleep and heart health
The Effects of External Nasal Dilator Strips on Sleep and Cardiovascular Health
This study is testing if wearing nasal strips while you sleep can help you breathe better, improve your sleep quality, and positively affect your heart health.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 30 Years |
| Sex | All |
| Sponsor | Florida State University Academic / other |
| Locations | 1 site (Tallahassee, Florida) |
| Trial ID | NCT06403098 on ClinicalTrials.gov |
What this trial studies
This interventional study aims to investigate whether wearing external nasal dilator strips during sleep can improve both objective and perceived sleep quality, as well as influence immediate post-waking blood pressure and heart rate variability. The nasal strips work by dilating the nostrils, which may enhance nasal breathing and reduce air resistance. By understanding the impact of these strips on cardiovascular and sleep health, the study seeks to provide valuable insights into their potential benefits. Participants will be monitored using mobile applications to track their health metrics.
Who should consider this trial
Good fit: Ideal candidates for this study are healthy adults aged 18-30 with a BMI under 30 who can use nasal dilator strips.
Not a fit: Patients with existing cardiovascular, respiratory, or other significant health conditions, as well as those unable to breathe through the nose, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved sleep quality and cardiovascular health for individuals using nasal dilator strips.
How similar studies have performed: While the specific use of nasal dilator strips in this context may be novel, related studies have shown that nasal breathing can positively affect cardiovascular health and sleep quality.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18-30 * BMI \<30 * Has a smartphone and is willing to download EliteHRV and OMRON mobile applications. * Able to use a nasal dilator strip Exclusion Criteria: * Overt cardiovascular (e.g., diagnosed hypertension), respiratory, neurological, renal, liver, and/or metabolic health conditions. * Current or recent (regular use within the past 6 months) use of tobacco or nicotine products (e.g., cigarettes). * Currently pregnant, trying to become pregnant, or lactating. * Inability to breathe through the nose.
Where this trial is running
Tallahassee, Florida
- Cardiovascular and Applied Physiology Laboratory — Tallahassee, Florida, United States (Recruiting)
Study contacts
- Principal investigator: Joseph Watso, PhD — Florida State University
- Study coordinator: Joseph D Vondrasek, MS
- Email: jdv22e@fsu.edu
- Phone: (850) 644-1281
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.